arrow
B

Benjamin Mou

bccancer kelowna
H指数:12
被引数:534

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Population-based analysis of single-fraction versus multi-fraction stereotactic ablative radiotherapy for early-stage non-small cell lung cancer

早期非小细胞肺癌单次分割与多次分割立体定向消融放疗的基于人群的分析

2026-09-260
PRE
Five-year follow-up of the SABR-5 trial: primary toxicity analysis of stereotactic ablative radiotherapy for up to five oligometastases

SABR-5试验的五年随访:针对最多五个寡转移灶的立体定向消融放射治疗的主要毒性分析

2026-05-150
OAAI
Treatment With Stereotactic Ablative Radiotherapy for patients with Up to 5 Oligometastatic cancer lesions: Long-Term Outcomes of the Nonrandomized Population-Based Phase 2 SABR-5 Clinical Trial
2026-01-220
PRE
Multinational Validation of Distant Metastasis Velocity as a Post-Progression Prognostic Score in Patients with Oligometastatic Cancer Treated with Metastasis-Directed Stereotactic Body Radiotherapy

多国验证远处转移速度作为接受转移灶定向立体定向体部放疗的寡转移癌患者中的一种疾病进展后预后评分

2025-08-230
OAAI
Impact of clinical target volume utilization on outcomes in patients with non-spine bone oligometastases treated with stereotactic ablative radiation therapy

立体定向消融放射治疗非脊柱骨寡转移患者中临床靶区应用对预后的影响

2025-05-210
PRE
Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial
2025-01-012
PRE
Predictors of Quality of Life Decline in Patients with Oligometastases treated with Stereotactic Ablative Radiotherapy: Analysis of the-Based SABR-5 Phase II Trial
2024-03-012
PRE
Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET
2024-02-030
OAAI
Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial
2023-05-0112
PRE
Progression-Free Survival and Local Control After SABR for up to 5 Oligometastases: An Analysis From the Population-Based Phase 2 SABR-5 Trial
2022-11-0127
PRE
Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial
2020-05-0586
OAAI
SUPR-3D: A randomized phase iii trial comparing simple unplanned palliative radiotherapy versus 3d conformal radiotherapy for patients with bone metastases: study protocol

SUPR-3D: 一项比较单纯非计划姑息性放疗与三维适形放疗治疗骨转移患者的随机iii期试验: 研究方案

2019-10-2810
OAAI